Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/1996
12/19/1996WO1996040747A1 Urokinase receptor ligands
12/19/1996WO1996040746A1 Lysyloxidase inhibitors
12/19/1996WO1996040745A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996WO1996040744A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa
12/19/1996WO1996040743A2 INHIBITORS OF FACTOR Xa
12/19/1996WO1996040742A1 Peptidyl heterocycles useful in the treatment of thrombin relateddisorders
12/19/1996WO1996040741A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996WO1996040740A1 Peptide and method of obtaining it
12/19/1996WO1996040739A2 Urethane mediated, gst specific molecular release systems
12/19/1996WO1996040738A1 Novel inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040726A1 Novel carbamate-based cationic lipids
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040637A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996WO1996040633A1 Small molecule inhibitors of rotamase enzyme activity
12/19/1996WO1996040627A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996WO1996040293A1 Structurally determined metallo-constructs and applications
12/19/1996WO1996040208A1 Novel mu opioid receptor ligands: agonists and antagonists
12/19/1996WO1996040206A1 Novel kappa receptor selective opioid peptides
12/19/1996WO1996040205A1 Metabolic effects of certain glutathione analogs
12/19/1996WO1996040204A1 Novel inhibitors of collagenase-1 and stromelysin-i metalloproteases, pharmaceutical compositions comprising same and methods of their use
12/19/1996WO1996040187A1 Surface-modifying copolymers having cell adhesion properties
12/19/1996WO1996040184A1 New cryptophycins from synthesis
12/19/1996WO1996040118A1 Thrombin inhibitors
12/19/1996WO1996039834A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
12/19/1996DE19521945A1 Kaskadenpolymere mit Iodaromaten Cascade polymers with iodoaromatics
12/19/1996DE19521412A1 Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung New cationic and polycationic amphiphiles containing these reagents and their use
12/19/1996CA2352900A1 Small molecule inhibitors of rotamase enzyme activity
12/19/1996CA2224191A1 Urethane mediated, gst specific molecular release systems
12/19/1996CA2224180A1 Ketoheterocyclic inhibitors of factor xa
12/19/1996CA2224113A1 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996CA2224110A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996CA2224076A1 Inhibitors of factor xa
12/19/1996CA2223500A1 Thrombin inhibitors
12/19/1996CA2223428A1 Novel mu opioid receptor ligands: agonists and antagonists
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2223088A1 Novel carbamate-based cationic lipids
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/19/1996CA2222923A1 Novel inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
12/19/1996CA2222690A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
12/19/1996CA2222586A1 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996CA2222183A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996CA2221146A1 Structurally determined metallo-constructs and applications
12/19/1996CA2196334A1 Urokinase receptor ligands
12/18/1996EP0748814A1 Novel aspartyldipeptideamide derivatives and sweetener
12/18/1996EP0748333A1 Antithrombotic agents
12/18/1996EP0748226A1 Block copolymers
12/18/1996EP0555479B1 Epoxysuccinamic acid derivative
12/18/1996EP0506914B1 Method for the diagnosis of hiv infections
12/18/1996CN1138335A Compounds with growth hormone releasing properties
12/18/1996CN1138334A Compounds with growth hormone releasing properties
12/18/1996CN1033584C Benzo-fused lactams that promote release of growth hormone
12/17/1996US5585498 Imidazole derivatives useful as synthetic intermediates
12/17/1996US5585486 Peptidic ketones as interleukin-1β-converting enzyme inhibitors
12/17/1996US5585397 Viricides
12/17/1996US5585376 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
12/17/1996US5585360 Thrombin inhibitors
12/17/1996US5585359 Inhibitors of farnesyl-protein transferase
12/17/1996US5585357 Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors
12/13/1996CA2165721A1 Novel aspartyldipeptide amide derivatives and sweetener
12/12/1996WO1996039409A1 Nitrosylated and nitrated superoxide oxidants and reductants
12/12/1996WO1996039407A1 Quinolizinone type compounds
12/12/1996WO1996039384A1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
12/12/1996WO1996039194A1 Novel cathepsin and methods and compositions for inhibition thereof
12/12/1996WO1996039173A1 A stabilized pharmaceutical formulation comprising growth hormone and lys-gly-asp-ser
12/12/1996WO1996039163A1 Aminopeptidase p inhibitors and uses thereof
12/12/1996WO1996034010A3 Inhibitors of farnesyl-protein transferase
12/12/1996CA2226429A1 Aminopeptidase p inhibitors and uses thereof
12/12/1996CA2222322A1 Quinolizinone type compounds
12/12/1996CA2221684A1 Novel cathepsin and methods and compositions for inhibition thereof
12/11/1996EP0747393A1 Thiazolo benzazepine containing dual action inhibitors
12/11/1996EP0747392A1 1,2-Diazepine containing dual action inhibitors
12/11/1996EP0747351A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/11/1996EP0746567A1 Novel opioid peptides for the treatment of pain and use thereof
12/11/1996EP0746566A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/10/1996US5583238 Method for making intermediates useful in synthesis of retroviral protease inhibitors
12/10/1996US5583233 Retroviral protease inhibiting compounds
12/10/1996US5583232 Treating human immunodeficiency virus infections
12/10/1996US5583198 Amino acids, peptides or derivatives thereof coupled to fats
12/10/1996US5583146 Heterocyclic thrombin inhibitors
12/10/1996US5582801 Apparatus for multiple simultaneous synthesis
12/08/1996CA2178355A1 Diazepine containing dual action inhibitors
12/08/1996CA2178352A1 Thiazolo benzazepine containing dual action inhibitors
12/05/1996WO1996038471A1 Dipeptides which promote release of growth hormone
12/05/1996WO1996038470A1 IMIDAZO[1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
12/05/1996WO1996038435A1 Dopamine agonists
12/05/1996CA2222960A1 Imidazo 1,5a pyridine derived serine protease inhibitors
12/04/1996EP0745680A2 Novel fungicidal agents LL-15G256g, d and e produced by LL-15G256 (Hypoxylon oceanicum)
12/04/1996EP0745093A1 New oligopeptides with affinity to opioid receptors
12/04/1996EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/04/1996EP0744954A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease
12/04/1996EP0480061B1 Hepatic disorder inhibitor
12/04/1996CN1137273A Quinolizinone type compounds
12/04/1996CN1137040A New mercaptoalanoyldipeptide compounds process for their preparation and pharmaceutical compositions containign them
12/03/1996US5580984 Retroviral protease inhibiting compounds
12/03/1996US5580979 Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
12/03/1996US5580896 Treatment of pain and colorectal cancer with dipeptoids of α-substituted Trp-Phe derivatives
12/03/1996US5580872 Administering in the treatment of bacterial infections
12/03/1996US5580855 Analgesics
12/03/1996US5580854 Substrate-related peptidyl-aldehyde inhibitors of the proteolytic activity of the multicatalytic proteinase complex
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 307